Avadel Pharmaceuticals
AVDL
#4586
Rank
A$3.08 B
Marketcap
A$31.40
Share price
0.00%
Change (1 day)
149.98%
Change (1 year)

Earnings for Avadel Pharmaceuticals (AVDL)

Earnings in 2025 (TTM): -A$5.79 Million

According to Avadel Pharmaceuticals 's latest financial reports the company's current earnings are A$0.24 Billion. In 2024 the company made an earning of -A$71.23 Million, an increase over its 2023 earnings that were of -A$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Avadel Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$5.79 Million-91.88%
2024 -A$71.23 Million-69.47%
2023 -A$0.24 Billion44.27%
2022 -A$0.17 Billion19.64%
2021 -A$0.14 Billion1732.84%
2020 -A$7.38 Million-86.83%
2019 -A$56 Million-65.92%
2018 -A$0.17 Billion-222.16%
2017 A$0.13 B-1053.49%
2016 -A$14.11 Million-112.59%
2015 A$0.11 B-185.94%
2014 -A$0.14 Billion66.04%
2013 -A$78.51 Million582.16%
2012 -A$11.51 Million-7.6%
2011 -A$12.46 Million-2.1%
2010 -A$12.73 Million32.52%
2009 -A$9.6 Million-64.36%
2008 -A$26.94 Million-52.93%
2007 -A$57.23 Million5.66%
2006 -A$54.16 Million17.86%
2005 -A$45.95 Million-375.09%
2004 A$16.7 M-406.44%
2003 -A$5.46 Million-145.2%
2002 A$12.05 M-363.36%
2001 -A$4.58 Million-80.62%
2000 -A$23.63 Million132.68%
1999 -A$10.16 Million-50.34%
1998 -A$20.45 Million54.85%
1997 -A$13.21 Million-28.35%
1996 -A$18.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.24 Billion 4,798.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$26.35 Million 457.62%๐Ÿ‡บ๐Ÿ‡ธ USA